FDA approves Protalix's (PLX) Gaucher Disease drug Elelyso
- Top 10 News for 6/27 - 7/1: Markets Rebound Following Brexit Fall; US Banks Gain on Stress Test Results; Tesla Under Fire Following Accident
- Wall St. ends higher for fourth straight day
- Harley-Davidson (HOG) Says Subject of Various Rumors; Won't Comment on Latest Speculation
- NHTSA Probes Tesla (TSLA) After Fatal Model S Autopilot Crash
- Caution: Wall Street Rumor Mill in Overdrive
The FDA approved Protalix's (NYSE: PLX) Gaucher Disease drug Elelyso
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ampio Pharma (AMPE) Provides Results from Ampion Trials; Primary End Point Was Not Met
- Ziopharm Oncology (ZIOP), Intrexon (XON) Enter Amended ECCs; Will Include Increased Investment
- ArQule (ARQL) Announces Prelim. Data on ARQ 087 Phase 1/2; Anticancer Activity Observed
Create E-mail Alert Related CategoriesFDA, Hot FDA News
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!